Abstract:Objective: To construct a kind of paclitaxel-loaded long-circulating nanoliposomes actively targeting lung tumor in order to improve the tissue distribution of paclitaxel in vivo, and to promote the safety and the anti-tumor efficacy of paclitaxel administration. Methods: The complex of arginine glycine-aspartic acid-e-amino hexanoic acid linker-palmitate (RGD-EACA-Pal) was synthesized by solid-phase synthesis method. The sterically stabilized liposome of paclitaxel (SSL-PTX) and the active lung cancer-targeting sterically stabilized liposome of paclitaxel (T-SSL-PTX) were prepared by thin film ultrasonication-dispersion method, respectively. The pharmacokinetics, tissue distribution and the anti-tumor effects of two different formulations of paclitaxel were evaluated after intravenous injection of taxol, SSL-PTX or T-SSL-PTX in tumor-bearing nude mice. The maximum tolerance doses (MTDs) of two different formulations of paclitaxel were determined in Kunming mice. Results: Transmission electron microscopy (TEM) image showed that both SSL-PTX and T-SSL-PTX shaped regularly round and dispersed uniformly, and these two particle sizes were (83.4±36.7) nm and (94.7±41.2) nm, respectively. The encapsulation efficiencies of both SSL-PTX and T-SSL-PTX were at or above 95%. In vivo, the circulation time of SSL-PTX or T-SSL-PTX was longer than taxol, and the pharmacokinetic parameters of SSL-PTX and T-SSL-PTX were similar. Tumor-targeting efficiency of T-SSL-PTX was better than that of SSL-PTX or taxol, as well as the tissue distribution of T-SSL-PTX in normal organs was at a relatively low level as compared with that of SSL-PTX or taxol, in contribution to RGD specifically targeting tumors. The MTDs of SSL-PTX and T-SSL-PTX were higher than that of taxol. Compared with SSL-PTX and taxol with the same dose of paclitaxel, the anti-tumor efficacy of T-SSL-PTX was improved significantly (P＜0.05); and the mice received T-SSL-PTX therapy with a longer interval or at a lower dose also achieved significant tumor growth retardation.Conclusion: The lung cancer-targeting long-circulating nanoliposomes of paclitaxel may increase the safety and anti-tumor efficacy of paclitaxel through improving its pharmacokinetics and tissue distribution in vivo. DOI:10.3781/j.issn.1000-7431.2011.03.004

Theraputic Effect of Lipid-Coated Microbubble Carrying Taxol on Rat with Intracranial C6 Glioma

The Targeted Therapeutic Effect of a Lipid-Coated Microbubble Carrying Taxol on C6 Glioma in Vivo and Vitro

Study of C6 Glioma Cell Lines' Inhibition by Taxol Carried by Lipid-Coated Microbubbles in Vitro

Therapeutic Effect of Local Implantation with Temozolomide/plga Microsphere in Treatment of Rat C6 Glioma in Vivo

Application of paclitaxel-poly(ethylene glycol)-poly(D,L-lactic acid) controlled-release ultrafine fibers against brain glioma in rat models

The Anti-Tumor Effects of Lung Cancer-Targeting Long-Circulating Paclitaxel-Containing Liposomes

Induction of neural differentiation in rat C6 glioma cells with taxol

Enhanced Efficacy of Functionalized Epirubicin Liposomes in Treating Brain Glioma-Bearing Rats.

Inhibition Effect of Hydroxycamptothecin Sustained-release Tablets Implanted into Brain on C6 Glioma in Rats

Co-encapsulation of borneol and paclitaxel by liprosomes improved anti-tumor effect in a xenografted glioma model

Investigation on the Inhibition Effects of Bone Marrow Mesenchymal Stem Cells with CD Gene on Glioma in C6 Rat*

Growth inhibition against intracranial C6 gliomas by stereotactic delivery of BCNU from controlled release of poly ( D,L-lactic acid) microspheres

Temozolomide/PLGA Microparticles: a New Protocol for Treatment of Glioma in Rats

Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting

Effect of Glutamate Receptor Antagonist Combined with Photodynamic Therapy on C6 Glioma Cells Implanted in Rat Brain

Growth Inhibition of Polylactic Acid Temozolomide Microspheres on SD Rat C6 Brain Glioma in Vitro and in Vivo

Preparation of Vinorelbine-tetrandrine Liposomes Modified with RGD and Study on the in vitro Antitumor Effect

[Intranasal Administration of Temozolomide for Brain-Targeting Delivery: Therapeutic Effect on Glioma in Rats].

Experimental study on the therapeutic effects of nimustine combined with cisplatin on C6 brain glioma

Inhibitive Effect Of Artemether On Tumor Growth And Angiogenesis In The Rat C6 Orthotopic Brain Gliomas Model

Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles.